[1] SULLIVAN A, LU X. ASPP:a new family of oncogenes and tumour suppressor genes[J]. Br J Cancer, 2007, 96 (2) :196-200.
|
[2] WANG Z, LIU Y, TAKAHASHI M, et al. N terminus of ASPP2binds to ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence[J]. Proc Natl Acad Sci U S A, 2013, 110 (1) :312-317.
|
[3] IWABUCHI K, BARTEL PL, LI B, et al. Two cellular proteins that bind towild-type but not mutant p53[J]. Proc Natl Acad Sci U S A, 1994, 91 (13) :6098-6102.
|
[4] MOSAVI LK, CAMMETT TJ, DESROSIERS DC, et al. The ankyrin repeat as molecular architecture for protein recognition[J]. Protein Sci, 2004, 13 (6) :1435-1448.
|
[5] SAMUELS-LEV Y, O'CONNOR DJ, BERGAMASCHI D, et al.ASPP proteins specifically stimulate the apoptotic function of p53[J]. Mol Cell, 2001, 8 (4) :781-794.
|
[6] TIDOW H, ANDREEVA A, RUTHERFORD TJ, et al. Solution structure of ASPP2 N-terminal domain (N-ASPP2) reveal saubiquitin-likefold[J]. J Mol Biol, 2007, 371 (4) :948-958.
|
[7] LIU K, YIN JM, DING W, et al. ASPP2 enhances the effect of DRAM induced autophagy on promoting apoptosis in Hep G2 cells[J]. Chin J Biochem Mol Biol, 2012, 28 (11) :1011-1017. (in Chinese) 刘凯, 殷继明, 丁渭, 等. ASPP2过表达可增强DRAM介导的自噬对Hep G2细胞的促调亡作用[J].中国生物化学与分子生物学报, 2012, 28 (11) :1011-1017.
|
[8] LIU K, WANG AN, JIANG T, et al. ASPP2 promotes p53-independent autophagy-induced apoptosis in Hep3B cells[J]. Chin J Biochem Mol Biol, 2013, 29 (7) :636-642. (in Chinese) 刘凯, 王安娜, 姜涛, 等. ASPP2以p53非依赖形式促进自噬引起Hep3B细胞凋亡[J].中国生物化学与分子生物学报, 2013, 29 (7) :636-642.
|
[9] WANG Z, LIU Y, TAKAHASHI M, et al. N terminus of ASPP2binds to Ras and enhances Ras/Raf/MEK/ERK activation to promote oncogene-induced senescence[J]. Proc Natl Acad Sci U S A, 2013, 110 (1) :312-317.
|
[10] BERGAMASCHI D, SAMUELS Y, JIN B, et al. ASPP1 and ASPP2:Common activators of p53 family members[J]. Mol Cell Biol, 2004, 24 (3) :1341-1350.
|
[11] LIU K, ZENG XW, JI XM, et al. Progresses in study on the apoptosis stimulating proteins of p53 family regulate autophagy[J]. J Clin Pathol Res, 2016, 36 (6) :859-863. (in Chinese) 刘宽, 曾现伟, 吉训明, 等. p53凋亡刺激蛋白家族对自噬调控作用的研究进展[J].临床与病理杂志, 2016, 36 (6) :859-863.
|
[12] WANG Y, WANG XD, LAPI E, et al. Autophagic activity dictates the cellular response to oncogenic RAS[J]. Proc Natl Acad Sci USA, 2012, 109 (33) :13325-13330.
|
[13] SHI Y, HAN Y, XIE F, et al. ASPP2 enhances oxaliplatin (LOHP) -induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy[J]. J Cell Mol Med, 2015, 19 (3) :535-543.
|
[14] SONG B, BIAN Q, ZHANG YJ, et al. Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation[J]. Mol Cancer, 2015, 14 (1) :177.
|
[15] XIE F, JIA L, LIN M, et al. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease[J]. J Cell Mol Med, 2015, 19 (1) :155-164.
|
[16] LIU K, SHI Y, GUO X, et al. CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2[J]. Cell Death Dis, 2014, 5:e1323.
|
[17] TURNQUIST C, WANG Y, SEVERSON DT, et al. STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression[J]. Proc Natl Acad Sci USA, 2014, 111 (27) :9834-9839.
|
[18] SAMUELS-LEVY, O'CONNORDJ, BERGAMASCHID, et al.ASPP proteins specifically stimulate the apoptotic function of p53[J]. Mol Cell, 2001, 8 (4) :781-794.
|
[19] LIU ZJ, ZHANG Y, ZHANG XB, et al. Abnormal m RNA expression of ASPP members in leukemia cell lines[J]. Leukemia, 2004, 18 (4) :880.
|
[20] LOSSOSIS, NATKUNAMY, LEVYR, et al. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma:Correlation with clinical outcome[J]. Leuk Lymphoma, 2002, 43 (12) :2309-2317.
|
[21] ZHU YP, WANG DJ, HE YH. Expression of Aspp1 and ASPP2protein in human brain glioma and its relationship with apoptosis[J]. Guangdong Med J, 2012, 33 (13) :1964-1968. (in Chinese) 朱泳鹏, 王东军, 何友虎.人脑胶质瘤中Aspp1和ASPP2蛋白的表达及其与细胞凋亡的相关性[J].广东医学, 2012, 33 (13) :1964-1968.
|
[22] VIVES V, SLEE E A, LU X. ASPP2:A gene that controls life and death in vivo[J]. Cell Cycle, 2006, 5 (19) :2187-2190.
|
[23] CHEN Y, LIU W, NAUMOVSKI L, et al. ASPP2 inhibits APPBP1-mediated NEDD8 conjugation to cullin-1 and decreases APP-BP1-induced cell proliferation and neuronal apoptosis[J]. J Neurochem, 2003, 85:801-809.
|
[24] ZHU C, BAO N, CHEN S, et al. Dioscin enhances osteoblastic cell differentiation and proliferation by inhibiting cell autophagy via the ASPP2/NF-κβpathway[J]. Mol Med Rep, 2017, 16 (4) :4922-4926.
|
[25] MA L, CHEN ZM, LI XY, et al. Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation[J]. Oncol Letters, 2013, 6 (5) :1313-1318.
|
[26] ZHENG KM, WU G, QIN XM, et al. Effects of XAV393 on proliferation and glycolysis of hepatocellular carcinoma cells[J]. Mod Oncol, 2016, 24 (13) :2023-2026. (in Chinese) 郑昆明, 吴刚, 秦晓明, 等. XAV939对肝癌细胞增殖及糖酵解的影响[J].现代肿瘤医学, 2016, 24 (13) :2023-2026.
|
[27] CALVISI DF, LADU S, GORDEN A, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma[J]. J Clin Invest, 2007, 117:2713-2722.
|
[28] ZHAO J, WU G, BU F, et al. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-richregion-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma[J]. Hepatology, 2010, 51 (1) :142.
|
[29] WU GB. The experimental research on the m RNA expression Aspp1, ASPP2 and the CpG island methylation of their promoters in hepatocellular carcinoma[D]. Nanning:Guangxi Med Univ, 2008. (in Chinese) 邬国斌.肝细胞癌中Aspp1、ASPP2基因表达及其启动子区CpG岛甲基化的实验研究[D].南宁:广西医科大学, 2008.
|
[30] CHEN R, WANG H, LIANG B, et al. Downregulation of ASPP2improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation[J]. Cell Death Dis, 2016, 7 (12) :e2512.
|
[31] National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol, 2018, 34 (5) :947-957. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南 (2018年更新版) [J].临床肝胆病杂志, 2018, 34 (5) :947-957.
|
[32] SINGH R, KAUSHIK S, WANG Y, et al. Autophagy regulates lipid metabolism[J]. Nature, 2009, 458:1131-1135.
|
[33] XIE F, JIA L, LIN M, et al. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease[J]. J Cell Mol Med, 2015, 19 (1) :155-164.
|
[34] WANG Y, WANG XD, LAPI E, et al. Autophagic activity dictates the cellular response to oncogenic RAS[J]. Proc Natl Acad Sci USA, 2012, 109:13325-13330.
|
[35] ZHANG L, CARDINAL JS, BAHAR R, et al. Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide[J]. Mol Med, 2012, 18:201-208.
|
[36] BRISTOL ML, DI X, BECKMAN MJ, et al. Dual functions of autophagy in the response of breast tumor cells to radiation:Cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3[J]. Autophagy, 2012, 8:739-753.
|
[37] XING X, LI LP, WANG L, et al. Changes and functions of hepatic macrophages in viral hepatitis C infection[J]. Chin J Clin Pharmacol Ther, 2017, 22 (9) :1072-1076. (in Chinese) 邢欣, 李丽萍, 王鹿, 等.丙型病毒性肝炎中肝脏巨噬细胞的变化及作用[J].中国临床药理学与治疗学, 2017, 22 (9) :1072-1076.
|
[38] ZHANG LL, FENG GH. Advances in hepatitis C virus core protein[J]. World Chin J Dig, 2008, 16 (18) :2019-2024. (in Chinese) 张莉莉, 冯国和.丙型肝炎病毒核心蛋白作用研究进展[J].世界华人消化杂志, 2008, 16 (18) :2019-2024.
|
[39] CAO Y, HAMADA T, MATSUI T, et al. Hepatitis C virus core protein interacts with p53-bindingprotein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis[J]. Biochem Biophys Res Commun, 2004, 315 (4) :788-795.
|